FrancisKEshunMD

Pediatric Hematology & Oncology • Phoenix, AZ

Attending at Phoenix Children's Hospital

Join to view full profile

Dr. Eshun is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Eshun's full profile

Already have an account?

Office
1919 E Thomas Rd
Bldg C, Room 2240
Phoenix, AZ 85016
Phone+1 602-546-4689

Fax+1 602-546-4683
Is this information wrong?

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2005 - 2008
Lincoln Medical and Mental Health CenterResidency, Pediatrics, 2002 - 2005
University of Ghana Medical SchoolClass of 1996

Certifications & Licensure

AZ State Medical License 2008 - 2024
OH State Medical License 2005 - 2009
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma Start of enrollment: 2011 Dec 01
Terminated
Phase 1, Phase 2
Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission Start of enrollment: 2012 Jun 01
Active, not recruiting
Phase 2
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer Start of enrollment: 2013 Mar 04
Completed
Not Applicable
Neuroblastoma Maintenance Therapy Trial Start of enrollment: 2016 Feb 01
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

63 citations
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
Giselle Saulnier Sholler, William S. Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, Kathleen A. Neville
Scientific Reports. 2018-09-27
45 citations
Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patients.
Pooja Hingorani, Mary Maas, Michael P. Gustafson, Paul S. Dickman, Roberta H. Adams
Journal for Immunotherapy of Cancer. 2015-08-18
28 citations
VEGF Blockade Enables Oncolytic Cancer Virotherapy in Part by Modulating Intratumoral Myeloid Cells
Mark A. Currier, Francis Eshun, Allyson Sholl, Artur Chernoguz, Kelly M. Crawford
Molecular Therapy. 2013-05-01

Hospital Affiliations

Phoenix Children'sPhoenix, Arizona